These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20381170)

  • 41. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.
    Pacchiarotti I; Valentí M; Colom F; Rosa AR; Nivoli AM; Murru A; Sánchez-Moreno J; Vieta E
    J Affect Disord; 2011 Mar; 129(1-3):321-6. PubMed ID: 20817267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mood stabilizers for patients with bipolar disorder: the state of the art.
    Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
    Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder.
    Beyer JL; Burchitt B; Gersing K; Krishnan KR
    Psychopharmacol Bull; 2008; 41(1):102-14. PubMed ID: 18362874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
    Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
    Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment.
    Özerdem A; Tunca Z; Çımrın D; Hıdıroğlu C; Ergör G
    Bipolar Disord; 2014 Feb; 16(1):72-82. PubMed ID: 24330379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
    Ghaemi SN; Goodwin FK
    J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.
    Perugi G; Frare F; Toni C; Tusini G; Vannucchi G; Akiskal HS
    Eur Arch Psychiatry Clin Neurosci; 2010 Oct; 260(7):553-60. PubMed ID: 20238120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium.
    Muti M; Del Grande C; Musetti L; Marazziti D; Turri M; Cirronis M; Pergentini I; Corsi M; Dell'Osso L; Corsini GU
    Psychiatry Res; 2015 Feb; 225(3):604-8. PubMed ID: 25547850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adherence to pharmacological treatment for juvenile bipolar disorder.
    Drotar D; Greenley RN; Demeter CA; McNamara NK; Stansbrey RJ; Calabrese JR; Stange J; Vijay P; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):831-9. PubMed ID: 17581447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.
    State RC; Frye MA; Altshuler LL; Strober M; DeAntonio M; Hwang S; Mintz J
    J Clin Psychiatry; 2004 Aug; 65(8):1057-63. PubMed ID: 15323589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.
    Young LT; Joffe RT; Robb JC; MacQueen GM; Marriott M; Patelis-Siotis I
    Am J Psychiatry; 2000 Jan; 157(1):124-6. PubMed ID: 10618026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.
    Swann AC; Bowden CL; Calabrese JR; Dilsaver SC; Morris DD
    Neuropsychopharmacology; 2002 Apr; 26(4):530-6. PubMed ID: 11927177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study.
    Muti M; Del Grande C; Musetti L; Marazziti D; Pergentini I; Corsi M; Turri M; Umberto Corsini G; Dell'Osso L
    Int Clin Psychopharmacol; 2013 Nov; 28(6):305-11. PubMed ID: 23873290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers.
    Huang TL; Hung YY; Lee CT; Chen RF
    Neuropsychobiology; 2012; 65(2):65-9. PubMed ID: 22222435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term treatment of bipolar disorder in children.
    Wagner KD
    J Clin Psychiatry; 2010 Sep; 71(9):e23. PubMed ID: 20923616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of excellent response to lithium: results from a nationwide register-based study.
    Kessing LV; Hellmund G; Andersen PK
    Int Clin Psychopharmacol; 2011 Nov; 26(6):323-8. PubMed ID: 21876441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
    Peselow ED; Clevenger S; IsHak WW
    Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Family conflict moderates response to pharmacological intervention in pediatric bipolar disorder.
    Townsend LD; Demeter CA; Youngstrom E; Drotar D; Findling RL
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):843-52. PubMed ID: 18315455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
    ; Geddes JR; Goodwin GM; Rendell J; Azorin JM; Cipriani A; Ostacher MJ; Morriss R; Alder N; Juszczak E
    Lancet; 2010 Jan; 375(9712):385-95. PubMed ID: 20092882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.